Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Standard Biotools Inc.
13G
LAB · 34385P108
|
6.0% |
8/14/2026
Event 6/30/2026
|
|||
| Long Focus Capital Management, LLC | 6.0% | ||||
| John Helmers | 6.0% | ||||
|
Aura Biosciences, Inc.
13G
AURA · 05153U107
|
4.9% |
8/14/2026
Event 6/30/2026
|
|||
| Long Focus Capital Management, LLC | 4.9% | ||||
| John Helmers | 4.9% | ||||
|
Onity Group Inc.
13G
ONIT · 675746606
|
6.3% |
5/15/2026
Event 3/31/2026
|
|||
| Long Focus Capital Management, LLC | 6.3% | ||||
| John Helmers | 6.3% | ||||
|
Tilly's, Inc.
13G
TLYS · 886885102
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Long Focus Capital Management, LLC | 0% | ||||
| John Helmers | 0% | ||||
|
Bicycle Therapeutics PLC
13G
BCYC · 088786108
|
6.6% |
5/15/2026
Event 3/31/2026
|
|||
| Long Focus Capital Management, LLC | 6.6% | ||||
| John Helmers | 6.6% | ||||
|
Adaptimmune Therapeutics PLC
13G
ADAPY · 00653A107
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Long Focus Capital Management, LLC | 0% | ||||
| John Helmers | 0% | ||||
|
FTAI Infrastructure Inc.
13G
FIP · 35953C106
|
4.9% |
11/14/2025
Event 9/30/2025
|
|||
| Long Focus Capital Management, LLC | 4.9% | ||||
| John Helmers | 4.9% | ||||
|
Tilly's, Inc.
13G
TLYS · 886885102
|
7.4% |
11/14/2025
Event 9/30/2025
|
|||
| Long Focus Capital Management, LLC | 7.4% | ||||
| John Helmers | 7.4% | ||||
|
Citi Trends Inc
13G
CTRN · 17306X102
|
2.9% |
11/14/2025
Event 9/30/2025
|
|||
| Long Focus Capital Management, LLC | 2.9% | ||||
| John Helmers | 2.9% | ||||
|
Azul SA
13G
AZULQ · 05501U106
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Long Focus Capital Management, LLC | 0% | ||||
| John Helmers | 0% | ||||
|
Citi Trends Inc
13G
CTRN · 17306X102
|
5.3% |
8/14/2025
Event 6/30/2025
|
|||
| Long Focus Capital Management, LLC | 5.3% | ||||
| John Helmers | 5.3% | ||||
|
Sight Sciences, Inc.
13G/A
Amendment 2
SGHT · 82657M105
|
6.0% |
5/15/2025
Event 3/31/2025
|
|||
| Long Focus Capital Management, LLC | 6.0% | ||||
| John Helmers | 6.0% | ||||
|
Quantum Corp /DE/
13G/A
Amendment 3
QMCO · 747906501
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Long Focus Capital Management, LLC | 0% | ||||
| John Helmers | 0% | ||||
|
Herbalife Ltd.
13G/A
Amendment 2
HLF · G4412G101
|
4.9% |
5/15/2025
Event 3/31/2025
|
|||
| Long Focus Capital Management, LLC | 4.9% | ||||
| John Helmers | 4.9% | ||||
|
Hyzon Motors Inc.
13G/A
Amendment 3
HYZN · 44951Y102
|
4.9% |
5/15/2025
Event 3/31/2025
|
|||
| Long Focus Capital Management, LLC | 4.9% | ||||
| John Helmers | 4.9% | ||||
|
Aura Biosciences, Inc.
13G/A
Amendment 3
AURA · 05153U107
|
6.6% |
5/15/2025
Event 3/31/2025
|
|||
| Long Focus Capital Management, LLC | 6.6% | ||||
| John Helmers | 6.6% | ||||
|
Ftai Infrastructure Inc.
13G
FIP · 35953C106
|
5.0% |
4/22/2025
Event 4/14/2025
|
|||
| Long Focus Capital Management, LLC | 5.0% | ||||
| John Helmers | 5.0% | ||||
|
Cellectis S.A.
13G/A
Amendment 3
CLLS · 15117K103
|
4.6% |
2/11/2025
Event 12/31/2024
|
|||
| Long Focus Capital Management, LLC | 4.6% | ||||
| Long Focus Capital Master, Ltd. | 2.5% | ||||
| Condagua, LLC | 2.1% | ||||
| John Helmers | 4.6% | ||||
| Glenn Helmers | 2.1% | ||||
|
Vincerx Pharma, Inc.
13G/A
Amendment 2
VINC · 92731L106
|
0% |
2/11/2025
Event 12/31/2024
|
|||
| Long Focus Capital Management, LLC | 0% | ||||
| Long Focus Capital Master, Ltd. | 0% | ||||
| Condagua, LLC | 0% | ||||
| John Helmers | 0% | ||||
| Glenn Helmers | 0% | ||||
|
Citi Trends, Inc.
13G/A
Amendment 1
CTRN · 17306X102
|
6.4% |
2/11/2025
Event 12/31/2024
|
|||
| Long Focus Capital Management, LLC | 6.4% | ||||
| Long Focus Capital Master, Ltd. | 4.5% | ||||
| Condagua, LLC | 1.9% | ||||
| John Helmers | 6.4% | ||||
| Glenn Helmers | 1.9% | ||||
|
Tilly's, Inc.
13G/A
Amendment 2
TLYS · 886885102
|
9.6% |
2/11/2025
Event 12/31/2024
|
|||
| Long Focus Capital Management, LLC | 9.6% | ||||
| Long Focus Capital Master, Ltd. | 5.4% | ||||
| Condagua, LLC | 4.1% | ||||
| John Helmers | 9.6% | ||||
| Glenn Helmers | 4.1% | ||||
|
Adaptimmune Therapeutics PLC
13G/A
Amendment 2
ADAPY · 00653A107
|
8.0% |
2/11/2025
Event 12/31/2024
|
|||
| Long Focus Capital Management, LLC | 8.0% | ||||
| Long Focus Capital Master, Ltd. | 5.2% | ||||
| Condagua, LLC | 2.8% | ||||
| John Helmers | 8.0% | ||||
| Glenn Helmers | 2.8% | ||||
|
Oportun Financial Corporation
13G/A
Amendment 1
OPRT · 68376D104
|
4.8% |
2/11/2025
Event 12/31/2024
|
|||
| Long Focus Capital Management, LLC | 4.8% | ||||
| Long Focus Capital Master, Ltd. | 3.2% | ||||
| Condagua, LLC | 1.7% | ||||
| John Helmers | 4.8% | ||||
| Glenn Helmers | 1.7% | ||||
|
Herbalife Ltd.
13G
HLF · G4412G101
|
5.0% |
2/5/2025
Event 1/29/2025
|
|||
| Long Focus Capital Management, LLC | 5.0% | ||||
| Long Focus Capital Master, Ltd. | 3.6% | ||||
| Condagua, LLC | 1.4% | ||||
| John Helmers | 5.0% | ||||
| Glenn Helmers | 1.4% | ||||
|
Sight Sciences, Inc.
13G
SGHT · 82657M105
|
5.0% |
1/23/2025
Event 1/16/2025
|
|||
| Long Focus Capital Management, LLC | 5.0% | ||||
| Long Focus Capital Master, Ltd. | 3.7% | ||||
| Condagua, LLC | 1.4% | ||||
| John Helmers | 5.0% | ||||
| Glenn Helmers | 1.4% | ||||
|
Aura Biosciences, Inc.
13G/A
Amendment 1
AURA · 05153U107
|
5.0% |
1/3/2025
Event 12/24/2024
|
|||
| Long Focus Capital Management, LLC | 5.0% | ||||
| Long Focus Capital Master, Ltd. | 3.6% | ||||
| Condagua, LLC | 1.4% | ||||
| John Helmers | 5.0% | ||||
| Glenn Helmers | 1.4% | ||||
|
Aura Biosciences, Inc.
13G
AURA · 05153U107
|
5.7% |
1/3/2025
Event 12/24/2024
|
|||
| Long Focus Capital Management, LLC | 3.6% | ||||
| Long Focus Capital Master, Ltd. | 3.6% | ||||
| Condagua, LLC | 1.4% | ||||
| John Helmers | 5.7% | ||||
| Glenn Helmers | 1.4% | ||||